1,3,4-Oxadiazole-sulfonamide hybrids: recent advances in biological activities, structure-activity relationships, and therapeutic applications. [PDF]
RSC AdvHosney A, Abdelhafez EMN, Mohamed MFA.
europepmc +1 more source
A novel and sustainable synthesis-functionalization strategy for the oxidative cyclization towards 2,5-disubstituted-1,3,4-oxadiazoles using bentonite-supported copper(i) iodide as a green catalyst. [PDF]
RSC AdvTran VQ +4 more
europepmc +1 more source
Effect of 1,3,4-oxadiazoles on expression of biofilm-associated bap gene in clinical isolates of multidrug-resistant Acinetobacter baumannii. [PDF]
Sci RepRahimbakhsh A +5 more
europepmc +1 more source
A Lactone-Enabled Approach to Metronidazole-Based Scaffolds. [PDF]
J Org ChemYu X +5 more
europepmc +1 more source
Synthesis of Benzazolyl Oxadiazolyl/Thiadiazolyl/Triazolyl Amines and Their Antimicrobial, Antioxidant, In Silico and In Vivo Anti-Inflammatory Activities. [PDF]
Chem BiodiversMadduru K +3 more
europepmc +1 more source
Ataluren for the treatment of people living with nonsense mutation Duchenne muscular dystrophy: a plain language summary of Study 041. [PDF]
J Comp Eff ResWu S +3 more
europepmc +1 more source
New 5-(pyridin-3-yl)-1,3,4-oxadiazoles derivatives as VEGFR2 inhibitors: <i>in silico</i> study, synthesis, and cytotoxicity evaluation. [PDF]
Res Pharm SciAbdulhussein AN, Oleiwi MA.
europepmc +1 more source
Synthesis and antimicrobial evaluation of hybrids methoxynaphthalene-<i>N</i>-acylhydrazones/1,3,4-oxadiazoles. [PDF]
Future Med ChemFrederico Rozada AM +9 more
europepmc +1 more source
Editorial: Advancing treatments for protozoan diseases: from resistance mechanisms to novel therapies. [PDF]
Front MicrobiolTouz MC, Arranz-Solís D, Nardelli S.
europepmc +1 more source
Conversion of N<sub>2</sub> into oxadiazoles promoted by a multinuclear samarium complex. [PDF]
Nat CommunShi X, Yuan Q, Chen Y, Xi Z, Wei J.
europepmc +1 more source